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ABSTRACT
Objectives Evaluate the outcomes and explore 
experiences of patients undergoing a residential combined 
physical and psychological programme (CPPP) for chronic 
low back pain.
Design A longitudinal observational cohort design, 
with a parallel qualitative design using semistructured 
interviews.
Setting Residential, multimodal rehabilitation.
Participants 136 adults (62 male/74 female) referred 
to the CPPP, 100 (44 male/56 female) of whom 
completed the programme, during the term of the study. 
Ten (2 male/8 female) participated in the qualitative 
evaluation.
Intervention A 3- week residential CPPP.
Outcome measures Primary outcome measures were the 
STarT Back screening tool score; pain intensity—11- point 
Numerical Rating Scale; function—Oswestry Disability 
Index (ODI); health status/quality of life—EQ- 5D- 5L 
EuroQol five- Dimension- five level; anxiety—Generalised 
Anxiety Disorder-7; depression—Patient Health 
Questionnaire-9. Secondary outcome measures were the 
Global Subjective Outcome Scale; National Health Service 
Friends and Family Test;.
Results At discharge, 6 and 12 months follow ups, there 
were improvements from baseline that were greater than 
minimum clinically important differences in each of the 
outcomes (with the sole exception of ODI at discharge). 
At 12 months, the majority of people considered 
themselves a lot better (57%) and were extremely likely 
(86%) to recommend the programme to a friend. The 
qualitative data showed praise for the residential nature 
of the intervention and the opportunities for interaction 
with peers and peer support. There were testimonies 
of improvements in understanding of pain and how to 
manage it better. Some participants said they had reduced, 
or stopped, medication they had been taking to manage 
their pain.
Conclusions Participants improved, and maintained long 
term, beyond minimum clinically important differences 
on a wide range of outcomes. Participants reported an 
enhanced ability to self- manage their back pain and 
support for the residential setting.
BACKGROUND
Low back pain (LBP) is the largest single 
cause of loss of disability- adjusted life years 
in the UK at 2313 per 100 000 population,1 
with economic costs rising from £1.6 billion 
in 20002 to over £2.1 billion in 2008.3 National 
Institute for Health and Care Excellence 
(NICE) guidelines bringing together current 
best evidence,3 including the recognition 
that opioids are not effective in long term 
LBP, were published to encourage consistent 
implementation of high quality management 
of LBP.4 The North of England Regional Back 
Pain and Radicular Pain Pathway operation-
alises these guidelines and preliminary data 
indicate that patients on this pathway demon-
strate clinically relevant improvements on a 
range of outcome measures.5
For those at high risk of disability, the 
pathway has an option of an intensive 
Combined Physical and Psychological 
Programme (CPPP). The CPPP is a 3- week 
residential multidisciplinary biopsychosocial 
rehabilitation intervention that includes phys-
ical, psychological and educational compo-
nents6 7 as recommended by NICE.8 A similar 
residential programme in the Netherlands 
showed clinically significant improvements 
in disability and quality of life that persisted 
into the long term9 10 with mild/moderate 
disability and being employed included as 
indicators of successful outcome.11
In our study, we aimed to evaluate early 
and longer- term changes in outcomes in 
patients referred into the CPPP from the 
North of England Regional Back Pain and 
Radicular Pain Pathway; and we aimed to 
gain insight into understanding the experi-
ences and perceptions of patients referred 
to the CPPP.
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This study had two parts. The primary part used a longitu-
dinal observational cohort design to investigate changes 
in clinical outcomes following the CPPP. The second part 
was a qualitative design using semi- structured interviews 
to investigate patients’ perceptions of the CPPP.
Public and Patient involvement
Patients or members of the public were not involved in 
the design, or conduct, or reporting, or dissemination 
plans of the research.
Participants
Participants in the longitudinal cohort study were all of 
the patients selected to undertake the CPPP during the 
study period. A subsample took part in the interviews 
after having provided informed consent to participate in 
the study. We used purposive sampling to recruit people 
who had completed the CPPP and people who had 
been offered a place but had declined this aspect of the 
pathway. The protocol for this study was registered on a 
public database (ISRCTN65093728).
Data collection
For the longitudinal cohort study, baseline question-
naires were completed by participants in the clinic in 
the presence of their clinicians as part of routine care on 
the Wednesday introductory session prior to beginning 
the 3- week programme on the following Monday. The 
baseline measures were the STarT Back screening tool 
score12; pain intensity—11- point Numerical Rating Scale 
(NRS)13; function—Oswestry Disability Index (ODI)14; 
health status/quality of life—EuroQol five- Dimension- 
five level15; anxiety—Generalised Anxiety Disorder 
(GAD-7)16; depression—Patient Health Questionnaire 
(PHQ-9).17 All, apart from STarT Back, were repeated at 
discharge in the clinic in the presence of the clinicians 
on the last day of the 3 weeks programme. Follow- up 
outcome measures were taken at 6 months and 12 months 
to coincide with planned catch- up days. These were 
predominantly completed in the clinic in the presence 
of clinicians. Where people did not attend for whatever 
reason, they were collected by post or by the clinicians 
over the phone. (These, like all of the outcomes, were 
taken as part of clinical practise and then made available 
to the research team. No record was taken of the exact 
numbers who completed by post or phone.) Additional 
measures, taken only at discharge, were the Global Subjec-
tive Outcome Scale18 and satisfaction with the service they 
had received—National Health Service (NHS) Friends 
and Family Test.19
For the qualitative study, participants took part in indi-
vidual semistructured interviews with one of the authors 
(SW) approximately 6–10 weeks after completion of the 
CPPP or, in the case of participants who had declined to 
take part, 6–10 weeks after they had declined. The inter-
view was structured to explore what we considered to be 
key issues and prompts allowed expansion of and from 
these. The a priori issues of interest were: history of back 
pain and previous treatment; changes in their back pain 
and factors they attributed to change; and opinions and 
experiences of the CPPP content and delivery. The inter-
views were undertaken in person at a participant’s home 
or workplace, audiorecorded and transcribed verbatim by 
an external agency.
Data analysis
For the longitudinal cohort study, change in outcome 
measures between baseline and discharge; baseline and 6 
months follow- up; and baseline and 12 months follow- up 
were analysed using paired t- tests (IBM SPSS Statistics for 
Windows, V.23.0, IBM). The magnitude of the change was 
compared against the minimal clinically important differ-
ence (MCID): EQ5D 0.03; NRS 1 point; ODI 10 points; 
GAD-7 10%; PHQ-9 10%.4
Framework analysis, assisted by NVivo (QSR Interna-
tional, V.10, 2014), was used with the transcripts of the 
qualitative interviews. The process followed the steps 
outlined by Ritchie and Spencer20: familiarisation; identi-
fying a thematic framework; indexing; charting; mapping 
and interpretation. The basis of the thematic framework 
was guided by the a priori issues of interest stated above 
but with freedom to allow for emerging themes.
RESULTS
Quantitative results
One hundred and thirty- six patients were invited to take 
part in the CPPP as part of their routine care, of whom, 
100 took part, a 74% uptake. The list of reasons for not 
taking part in the CPPP are provided in table 1.




Could not be contacted 8
Did not attend 6
Work commitments 6
Child care commitments 4
Content to self- manage 2
Family issues 2




Considered it a waste of time 1
Awaiting emergency scan 1
Trialling spinal injection with consultant 1
Out of geographical area and IFR 
declined
1
CPPP, combined physical and psychological programme; IFR, 
Individual funding request.
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The baseline characteristics of those who did and did 
not take part in the CPPP programme are shown in 
table 2. Compared with those who did attend, those who 
did not take part were younger and more affluent. Sex 
and, importantly, STarT Back scores were not found to be 
statistically significant between the two groups.
Differences between baseline and each of the three 
post- treatment time points (discharge, 6 and 12 months 
follow- up) are shown in tables 3–5). At discharge, 
there were statistically significant improvements in 
pain, disability, quality of life, anxiety and depression. 
The improvements in pain, quality of life, anxiety and 
depression were all greater than the MCID threshold for 
clinical significance. For disability, the mean improve-
ment of eight points for the ODI was below the MCID 
of ten points. At 6 and 12 months, the clinically signif-
icant improvements in pain, quality of life, anxiety and 
depression were maintained; and the statistically signif-
icant improvement in disability from baseline was now 
above the MCID. These clinically important improve-
ments persisted at 12 months (and in the outcomes of 
pain and anxiety the direction of change was in improve-
ments more marked at 12 months). At 12 months, the 
majority of people considered themselves a lot better 
(57%) and were extremely likely (86%) to recommend 
the programme to a friend (table 6).
Qualitative results
Ten patients were interviewed (8 women/2 men, age 
range 35–75). Eight had undertaken the CPPP, while two 
(both women) had declined. Four themes were described: 
experiences of back pain; experiences of the CPPP; expe-
riences after participating in the CPPP; recommenda-
tions to others.
Experiences of back pain
The theme describes participants’ historical experiences 
outwith the pathway. Duration of pain ranged from 2 
years to over 25 years. All participants reported that their 
back pain had either remained the same or had worsened 
over time. Most attributed their back pain to a particular 
event, lifting, an accident or as a result of an injury or 
issue with another part of their body. No clear pathway 
of care could be identified from the discussion with the 
participants. Typically, participants had been referred to 
a physiotherapist or a consultant. Expectations at each 
Table 2 Characteristics of people who joined and those who declined the CPPP
Joined (n=100) Declined (n=36) P value
Age (years) 46.3 (12.2) 39.3 (11.8) 0.004
Sex (female) 56.0% 50.0% 0.537
Socioeconomic status 5 (1–7) 2.5 (1–4) 0.012
STarT Back score 7.4 (1.5) 7.1 (1.7) 0.422
STarT Back risk (low risk) 3.0% 3.2% 0.893
Symptom duration (months) 120 (36–240) 72 (24–192) 0.178
Data are mean score (SD), percentage (%) or median (IQR). Not all participants provided data for each of the variables, the total for each 
variable is provided. Joined CPPP group: age (n=100), sex (n=100), socioeconomic status (n=95), STarT Back score (n=73), STarT Back 
risk=dichotomy of scores: low risk=score of 0–3; score of >3= at risk (n=73), symptom duration (n=117). Declined CPPP group: age (n=36), 
sex (n=36), socioeconomic status (n=34), STarT Back score (n=31), STarT Back risk=dichotomy of scores: low risk=score of 0–3; score of >3= 
at risk (n=31), Symptom duration (n=36).
CPPP, combined physical and psychological programme.







(95% CI) P value
Pain NRS (0–10)* 6.9 (1.6) 5.3 (1.9) −1.6 (-1.9, to −1.2) <0.001
ODI (0–100)* 47.2 (15.2) 39.1 (15.6) −8.1 (-9.8, to −6.4) <0.001
EQ- 5D (1 to −0.594)† 0.38 (0.24) 0.55 (0.21) 0.17 (0.13, 0.21) <0.001
EQ- 5D VAS (0–100)† 49.1 (19.8) 62.8 (20.2) 13.7 (9.9, 17.4) <0.001
GAD-7 (0–21)* 10.4 (6.3) 6.1 (5.0) −4.4 (-5.5, to −3.2) <0.001
PHQ-9 (0–27)* 12.8 (7.3) 6.8 (5.4) −6.0 (-7.3, to −4.7) <0.001
Not all participants provided data for each of the variables, the total for each variable is provided.
*Higher NRS, ODI, GAD-7 and PHQ-9 scores indicate poorer outcomes.
†Lower EQ- 5D and EQ- 5D VAS scores indicate poorer outcomes.
EQ- 5D, EuroQol five- Dimension Questionnaire (n=96); GAD-7, Generalised Anxiety Disorder Screener (n=92); NRS, Numerical Rating Scale 
(n=96); ODI, Oswestry Disability Index (n=95); PHQ-9, Patient Health Questionnaire (n=89); VAS, Visual Analogue Scale (n=96).
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point of contact were to relieve the pain and to check for 
any damage to their spine.
Experiences of the CPPP
Insights into reasons for not accepting the opportunity to 
take part in the CPPPP came from two participants. One 
(CPPP 5) was self- employed and could not afford to take 
the time off work.
I don’t get paid if I’m not at work and that was the 
one thing. I knew that I couldn’t afford to not have 
that wage. Had there been some sort of funding, then 
I would have been happy to say to my employer, look 
I’m going to be on the sick for three weeks, this is why 
I’m doing it, and I would have done it, gladly. I would 
have liked to have tried it, had I been able to get some 
form of sick pay from my company, I would have liked 
to have gone on it. I think just for the mental side of 
it more than anything else. (CPPP 5)
This was also a problem for the other participant (CPPP 
6) coupled with an expectation that it would not address 
their needs—from the quote this appears to be based on 
a misconception following an initial consultation.
…it didn’t suit me,…I deal a lot with CBT with the 
kids that I work with and I just felt, I felt a little bit 
annoyed that I felt like I was being told I didn’t really 
have the pain, that it was all sort of imagined pain. 
As soon as I came out I knew I didn’t want to do the 
programme. I couldn’t…for time constraints with 
work. (CPPP 6)
Prior expectations formed part of the experience of 
those who did attend the CPPP. These ranged from being 
unsure of what to expect but willing to give it a try, to 
misplaced expectations of becoming totally pain- free.
I was over the moon, because I thought I was going 
to fixed to be quite honest, I thought I’d come out of 
there in no pain, or anything. (CPPP 4)
Another participant had their similar expectation 
tempered by the clear messages given out at the start of 
the programme that the aims were to understand and 
manage pain.
To be honest I did think it was going to be a cure. 
But it was set out so well, and I couldn’t speak highly 







(95% CI) P value
Pain NRS (0–10)* 6.6 (1.8) 4.4 (2.2) −2.2 (−2.8 to −1.6) <0.001
ODI (0–100)* 45.7 (14.3) 35.5 (18.3) −10.2 (−14.1 to −6.3) <0.001
EQ- 5D (1 to −0.594)† 0.36 (0.25) 0.56 (0.26) 0.21 (0.13 to 0.28) <0.001
EQ- 5D VAS (0–100)† 48.1 (19.4) 62.0 (23.3) 14.0 (7.9 to 20.1) <0.001
GAD-7 (0–21)* 9.7 (6.2) 6.3 (6.5) −3.5 (−5.2 to −1.7) <0.001
PHQ-9 (0–27)* 11.9 (7.8) 7.5 (6.9) −4.4 (−6.3 to −2.6) <0.001
Not all participants provided data for each of the variables, the total for each variable is provided.
*Higher NRS, ODI, GAD-7 and PHQ-9 scores indicate poorer outcomes.
†Lower EQ- 5D and EQ- 5D VAS scores indicate poorer outcomes.
EQ- 5D, EuroQol five- Dimension Questionnaire (n=51); GAD-7, Generalised Anxiety Disorder Screener (n=49); NRS, Numerical Rating Scale 
(n=52); ODI, Oswestry Disability Index (n=52); PHQ-9, Patient Health Questionnaire (n=48); VAS, Visual Analogue Scale (n=51).







(95% CI) P value
Pain NRS (0–10)* 7.1 (1.6) 4.2 (1.8) −2.9 (−3.5 to −2.2) <0.001
ODI (0–100)* 51.5 (14.5) 36.4 (17.7) −15.1 (−20.6 to −9.7) <0.001
EQ- 5D (1 to −0.594)† 0.26 (0.22) 0.56 (0.22) 0.30 (0.21 to 0.40) <0.001
EQ- 5D VAS (0–100)† 38.2 (16.2) 65.4 (18.3) 27.2 (19.6 to 34.9) <0.001
GAD-7 (0–21)* 12.4 (6.4) 5.6 (5.2) −6.7 (−9.5 to −4.0) <0.001
PHQ-9 (0–27)* 15.2 (7.0) 7.4 (5.9) −7.8 (−10.8 to −4.9) <0.001
Not all participants provided data for each of the variables, the total for each variable is provided.
*Higher NRS, ODI, GAD-7 and PHQ-9 scores indicate poorer outcomes.
†Lower EQ- 5D and EQ- 5D VAS scores indicate poorer outcomes.
EQ- 5D, EuroQol five- Dimension Questionnaire (n=27); GAD-7, Generalised Anxiety Disorder Screener (n=26); NRS, Numerical Rating Scale 
(n=27); ODI, Oswestry Disability Index (n=27); PHQ-9, Patient Health Questionnaire (n=26); VAS, Visual Analogue Scale (n=27).
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enough of the programme, almost right from day one 
that this isn’t a cure, it’s more about understanding 
pain. (CPPP 8)
Participants who attended the programme were, gener-
ally, very positive about it, in some cases describing it 
as ‘brilliant’ and ‘excellent’. In particular, participants 
reported that they enjoyed the physical activity aspects of 
the programme.
…but we’d said that if you had a pool session every 
morning it just gave you that energy to do the rest of 
the day because some of some of the days were very, 
very tiring. (CPPP 3)
This participant echoed sentiments from others that 
there could be more of this content.
I would have preferred for it to be more physical 
activity…I mean [the] hydrotherapy was brilliant. It 
was very good and the gym, excellent; I even got to 
jog on a treadmill by the end of it like. (CPPP 1)
One participant reported how the education component 
of the CPPP helped overcome initial fears of exercise and 
activity.
So from an exercise point of view, that’s given me a 
lot more confidence knowing that I can do it without, 
it’s not going to cause any flare- ups unless I overdo 
it, if that makes sense?…the pain management 
modules were excellent, getting some really good 
understanding. (CPPP 10)
In general, the pain education sessions were highly 
praised as helping to better understand the reasons for 
their pain, alleviating a developed fear of being active, 
and helping to learn how to manage pain better.
…just the way it was broken down and explained 
about the pain and the mindfulness and everything. 
(CPPP 9)
Some participants reported initial anxiety and reticence 
about the residential nature of the programme. However, 
having taken part in the programme, participants were 
positive.
It’s necessary I think to stay away because I actually 
found it hard coming back home on the first 
Thursday. Yeah, I found it difficult but, yeah, it needs 
to be residential. (CPPP 3)
The peer support available through being in a group- 
based, residential programme was roundly praised
I do think it benefited us all, having a big group of 
people…. Like I said, being in a group with people 
who know what you’re going through and being 
able to talk about it. (CPPP 1) and one participant 
described the residential setting as adding value to 
the peer support.
It’s brilliant, you get cocooned in that little group and 
you’re all trying to help each other and feeding off 
each other, it was brilliant. (CPPP 2)
Aspects of the programme that were less well received 
included the sessions on dietary advice. In addition, there 
were mixed feelings voiced around the mindfulness and 
meditation sessions on the programme.
Yeah, and the alternative, the alternative things; the 
meditations and that I’m not a big sort of believer in 
that sort of thing. (CPPP 2)
I think the stretches and the mindfulness. [aspects of 
the programme that were particularly good] (CPPP 
7)
Experiences after participating in the CPPP
All participants reported that they had experienced 
back pain since taking part in the CPPP. There were 
differing opinions on how they would deal with this pain 
and whether they would visit their general practitioner 
(GP) about the pain. Mostly, participants suggested that 
they felt better able to manage further episodes of back 
pain through the education and understanding they had 
obtained by attending the programme.
Yeah, because I know my pain now, I know exactly 
what the pain is. So I would be able to think oh hang 
on a minute, that’s a bit different. Yeah. I’m dealing 
with it a lot more effectively, I’m not just taking 
Tramadol, and just getting on with it. (CPPP 3)
I made this list, and mine was remembering just a 
little caption that says remember it’s only back pain, 
you can’t do anything to break it you know, it’s just a 
flare- up. (CPPP 7)
Table 6 Global subjective outcome and patient satisfaction
Discharge 6 months 12 months
GSOS n=97, % n=51, % n=28, %
  Completely better 0.0 2.0 3.6
  A lot better 48.5 39.2 57.1
  Moderately better 28.9 27.5 21.4
  A little better 0.0 11.8 7.1
  Same 6.2 13.7 7.1
  Worse 0 5.9 3.6
FFT n=97, % n=51, % n=28, %
  Extremely likely 84.5 78.8 85.7
  Likely 15.5 17.3 14.3
  Neither likely nor 
unlikely
0.0 1.9 0.0
  Unlikely 0.0 0.0 0.0
  Extremely unlikely 0.0 1.9 0.0
  Don’t know 0.0 0.0 0.0
FFT, Friends and Family Test; GSOS, Global Subjective Outcome 
Scale.
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Some suggested that they felt able to significantly reduce, 
or stop taking altogether, the strong pain relief that they 
had previously been taking for their pain.
I was on the morphine, I just took myself off them 
because I was having horrendous nightmares…and I 
thought no, I’m not taking no more of them. So I just 
stick with the codeine now, I mean they explained 
how it works and what it does and things like that, 
and, yeah, I do understand more about my painkillers 
now. (CPPP 4)
Others stated that they would return to their GP for back 
pain issues but that it would be more likely for them to 
return only if there was a specific incident or a change 
from the back pain they were used to experiencing.
I mean if I’ve got a lot of pain, I would go and see my 
GP anyway…so if I had a real flare- up of back pain 
then yeah I’d go and see my GP. (CPPP 7)
I don’t think I would do, because I know there’s no 
magic pill, I know what to do to prevent it. So unless 
there was something that happened that presented 
itself in an entirely different way there’s no point. 
(CPPP 8)
Recommendations to others
Some participants said they had spoken to other people 
about back pain and that they had promoted the messages 
they had been given on the programme. They said they 
had encouraged people not to be afraid of being active 
and that it was likely to be more beneficial than to do 
harm.
To not be fearful of exercise and not get out and not 
try stuff. That it’s alright for it to hurt sometimes, but 
in the long run you’re doing yourself better. (CPPP 
1)
Also, they suggested that they had told people that the 
CPPP was excellent and, if they were offered it, they 
should attend.
DISCUSSION
We aimed to evaluate the outcomes of patients referred 
into the CPPP and explore their experiences. The quan-
titative analysis showed clinically important improve-
ments following the CPPP in pain, quality of life, anxiety 
and depression that were, at least, sustained over a time 
period of 12 months. The findings are consistent with the 
performance of a similar residential programme in the 
Netherlands9 10 and demonstrate the effectiveness of the 
CPPP as a mode of operationalising the NICE guidelines 
in a real- world setting within the context of an integrated 
care pathway.
Perhaps the most interesting aspects of the qualitative 
findings were the insights into the value of the residen-
tial nature of the intervention. There were many positive 
comments about the residential requirements including 
the extra opportunities it offered for interaction with 
peers and peer support that have been shown to be of 
benefit in group- based delivery.21–24 While most people 
offered a place on the CPPP took it up, some (26%) did 
not. The identification of work commitments as a barrier 
to participation is important in light of previous work, 
which showed that being in employment was a factor 
in successful outcome.11 This highlights potential bene-
fits of liaison with occupational health services, an area 
of need in the provision of musculoskeletal services and 
pain management services in general.25
Most of participants’ historical descriptions described 
a long and frustrating process of seeking a cure. Some 
reported still having had expectations of a cure at the 
start of the programme, although they recognised 
that they were informed that it was about empowering 
them to live with their pain. Within that context, the 
CPPP educational component in place to overcome 
these beliefs, based on the Pain Neuroscience Educa-
tion programme,26 27 was highly praised. Participants 
reported that it helped them to better understand their 
pain and begin to learn how to manage it better. This 
knowledge enhancement and understanding is reported 
in other studies as being similarly important in helping 
them toward self- management.21–24 Attributions of better 
understanding of pain to an improved ability to manage 
further episodes are consistent with findings from a 1- year 
follow- up of a multimodal non- residential programme24; 
this could help to explain the sustained long- term bene-
fits following the CPPP.
The main limitation of the quantitative analysis is the 
lack of a control group. That was outwith the design of 
the study and we have been careful to stay away from 
explicit statements of cause and effect. Nevertheless, the 
findings are consistent with those studies above that used 
more controlled experimental designs. The work has 
been carried out in the North East of England and thus 
the findings may not be generalisable to other regions. 
However, the pathway being delivered follows national 
guidelines and is closely aligned to the UK’s national back 
pain pathway increasing the generalisability of the work. 
A further limitation of this work was the relatively narrow 
focus on clinical outcomes with no data about important 
social impacts. In the case of the qualitative study, the 
findings are not as comprehensive as would be with a 
more fully layered purposive sampling strategy with more 
participants and the findings are illustrative rather than 
generalisable.
Future work should explore the impact of this and 
similar programmes in other regions on wider social 
issues of importance to participants. The environment 
component of the International Classification of Func-
tioning, Disability and Health provides a useful framework 
for this.28 A key part of the programme is its residential 
nature and there is an obvious need to compare this 
with a programme of similar aims and content delivered 
in non- residential form. An important part of this, and 
an important area of research on its own, would be to 
continue to explore the issue of negotiating employment 
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commitments with programme access taking account of 
the gaps between NHS services and occupational health 
services.25
CONCLUSION
This study found that patients who attended the residen-
tial CPPP within the North of England Regional Back 
Pain and Radicular Pain Pathway improved on a wide 
range of outcomes by a clinically meaningful amount and 
these improvements were sustained in the long term (and 
possibly increased for pain and anxiety). Uptake of the 
referral to the pathway was high and participants’ expe-
riences of the programme were predominantly positive 
particularly regarding the physical activity and educa-
tional components. Participants reported an enhanced 
ability to self- manage their back pain after undergoing 
the programme.
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